See also this year's filing and all EDGAR filings for this company.
PDF Report 0001135906_2012_Epirus_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Keryx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001135906, Epirus Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 51,207,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 21,546,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,258,000 |
| 3 | remainder_Assets | 1,872,000 |
| 4 | LiabilitiesCurrent | 15,544,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,400,000 |
| 9 | ResearchAndDevelopmentExpense | 35,294,000 |
| 10 | remainder_Expenses | 4,689,000 |
| 11 | remainder_Revenues | 8,184,000 |
| 12 | remainder_NetIncome | 156,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 79,883,000 |
| 1 | Liabilities | 15,544,000 |
| 2 | Expenses | 50,383,000 |
| 3 | Revenues | 8,184,000 |
| 4 | StockholdersEquity | 64,339,000 |
| 5 | NetIncome | -42,043,000 |
| 6 | ComprehensiveNetIncome | -42,043,000 |
| 7 | BaseVar | 77,075,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.06 |
| 9 | EconomicCapitalRatio | 3.06 |
Edgar->Model Mapping
Feature Distribution
